Poliovirus-infected cells contain a previously unrecognized particle which appears to be an intermediate in virion synthesis and therefore has been named proviron. It sediments at about 125S, contains the three procapsid proteins, VP-O, VP-1, and VP-3, and has 35S viral RNA. It is disrupted both by sodium dodecyl sulfate and EDTA but the RNA resists digestion by ribonuclease. Pulsechase experiments and studies employing the virus-specific inhibitor, guanidine, all indicate that the proviron is formed by combination of newly made RNA with the procapsid. Cleavage of VP-0 to form VP-2 and VP-4 follows formation of the provirion and would be the final step in poliovirus morphogenesis.
Poliovirus morphogenesis involves a series of steps in which the capsid proteins are processed by proteolysis and are aggregated into structures of increasing size (3) . The capsid proteins are translated from the viral genome into a single polypeptide, called NCVP 1 (14, 22) . This polypeptide is cleaved to generate three proteins: VP-0, VP-1, and VP-3 (11, 13, 15, 21) . Units of increasing complexity consisting of equimolar amounts of these three proteins are then assembled and combined with RNA to form the finished virion.
We have previously presented evidence that the protein complex to which RNA is added is a completed shell called the procapsid which sediments at about 80S (15) . The latter stages of morphogenesis involve both union of the RNA and protein and a final proteolytic cleavage in which the VP-0 is split into VP-2 plus VP-4. The mature virion sediments at about 155S.
The present investigation is concerned with the isolation of a new poliovirus-specific ribonucleoprotein particle which appears to be a new intermediate in the pathway of poliovirus morphogenesis and which appears to be the immediate precursor of the virion. It consists of the procapsid proteins plus viral RNA and we have provisionally named it the provirion to denote its apparent role as the progenitor of the virion.
MATERIALS AND METHODS
The growth of suspended HeLa (Fig. 1 ). 3H-leucine was recovered in virions (155S), procapsid (80S), and low molecular weight material. "4C-uridine was incorporated into virions, viral ribonucleoprotein (87S) (6) , and lower molecular weight material. Both labels also appeared in a structure not previously recognized which sedimented at about 125S. We call this structure the provirion, a designation we will justify by the evidence presented below.
Components of the provirion. The protein content of the provirion, labeled with radioactive leucine, was analyzed by polyacrylamide gel electrophoresis in the presence of SDS. Electrophoresis of provirion proteins mixed with either proteins of virion or procapsid (Fig.  2) showed that provirion contained the same 95 ,000 x g for 4 h in theSW 27 rotor at 4 C. A260 and radioactivity were determined in fractions from the gradients as described previously (5) . Arrows indicate the position of virion (V), provirion (PV), procapsid (PC), and viral ribonucleoprotein (vRNP). Polyacrylamide gel electrophoresis of provirion proteins. Cells infected for 3 h were labeled with 3H-leucine or 14C-leucine for 30 min and cytoplasmic extracts were prepared and fractionated as described in Fig. 1 . Samples of poliovirion, provirion, and procapsid were prepared for electrophoresis and analyzed on 10% acrylamide-ethylene diacrylate gels at 100 V for 6 h. After electrophoresis, gels were removed from tubes, sliced, and radioactivity was assayed (C. The RNA of provirion was analyzed by sucrose gradient velocity sedimentation iFi the presence of a differentially labeled preparation of virion RNA (Fig. 3) , Most of the provirion RNA sedimented indistinguishably from virion RNA.
Propprties or the provirion. The stability of lebeled provirion to various tr6atnients was studied in order to provide an indication of the structure of the particle. When ;an extract of cells labeled with both uridine and leucine was treated with ribonuclease, the provirion was found to be stable to the enzyme (Fig. 4) , indicating that the RNA of the particle is protected by the protein. (Fig. 5) ; as is evident in Fig. 5 and from previous studies (20) , the virion is SDS-resistant. Treatment of the provirion with EDTA also disrupted it and liberated separated procapsid and viral RNA (Fig. 6) . The virion is resistant to, EDTA as evidenced by the small remaining peak of labeled virion in Provirion as precursor of virion. In order to investigate whether the provirion might be a precursor of the virion, a number of approaches were used. First of ill, the labeling of procapsid a9yd provirion in the presence of guanidine was studied. Guanidline is able to inhibit the production of any new viral RNA which can act as precursor to virion RNA (1, 2, 12) and if provirion is on the pathway of virion production, one would expect that guanidine would inhibit its production. As seen in Fig. 7 , cells labeled with 3H1-leucine in the presence of guanidine and maintained in guanidine-containing medium did tiot synthesize any provirion although, in agreement with previous results (15) , they did synthesize procapsid.
A second approach to the analysis of the role of provirion was a study of the kinetics of labeling of procapsid, provirion, and virion under conditions where virions were being produced. The experiment was performed by labeling cells with 3H-leucine in the presence of guanidine and then both adding an excess of unlabeled leucine and removing the guanidine. It was adjusted to 0.3 M NaCl, 0.03 M Na citrate, and half was exposed to pancreatic ribonuclease A (10 pg/ml) for 5 min at 37 C. Samples were analyzed on 15 to 30%0 sucrose gradients in 0.3 M NaCl, 0.03 M Na citrate, as described in Fig. 1 . a, Not exposed to ribonuclease; b, cytoplasmic extract exposed to ribonuclease. equal height were observed. As time passed, the amount of virion increased relative to provirion. The quantitation of this data is shown in Fig.  8F . Here it is evident that with time the amount of label in procapsid decreased, whereas the amounts in both virion and provirion increased. Initially, label in provirion increased more rapidly than in virion. At later times, the labeling of provirion began to reach a plateau. These kinetics are consistent with the provirion being a precursor of the virion. In this experiment, the total amount of label in the three particles increased slightly over the period of sampling because there was continual generation of procapsid from the polypeptides labeled during the exposure to 3H-leucine.
In a third type of experiment, cells were exposed to 3H-leucine, and labeled virion, provirion, and procapsid were allowed to form. Then guanidine was added to the cells. Samples were taken at various times and analyzed on sucrose gradients. Figure 9 shows that in the period after guanidine addition, radioactivity in provirion disappeared from the sucrose gradient pattern. Graphic representation of the data from this experiment (Fig. 10) showed that the decrease in radioactivity in provirion was paralleled by an approximately eqiual increase of radioactivity in virion, strongly supporting the concept that provirion is a precursor of virIon.
Radioactivity in procapsid continued to increase after guanidine treatment as would be expected from earlier results (15) .
DISCUSSION
Analyses of poliovirus-infected HeLa cells have revealed a previously undetected, virusspecific particle sedimenting at about 125S.
This particle, which we call the provirion, is labeled with both uridine and leucine-the uridine is found in viral RNA molecules, the leucine is found in the three procapsid proteins, J. VIROL. Labeled cytoplasmic extracts were made as described in Fig. 4 , and provirion purified on a sucrose gradient. Fractions containing provirion were harvested; half of the sample was made 0.5% SDS and the other half remained in RSB. Samples were layered onto a linear sucrose-RSB gradient and analyzed as described in Fig. 1 . a, Provirion not exposed to SDS; b, provirion exposed to SDS.
VP-0, VP-1, and VP-3. The provirion is less stable than the virion to various treatments. Like the procapsid, it is sensitive to SDS. Its sensitivity to EDTA is its most unique characteristic and may explain why it has not been noticed previously. The RNA of the particle resists digestion with ribonuclease, suggesting that the RNA is interior to and protected by the protein. Because the particle is unstable in CsCl we have not been able to ascertain its buoyant density.
The role of provirion as a precursor to the virion cannot be rigorously proven by in vivo kinetic experiments but a number of results are consistent with such a role and very special circumstances would have to pertain if it is not a precursor. First, its structure is just that of precursor-it contains viral RNA and procapsid proteins and it needs only the final cleavage of VP-0 to become a virion. Second, the movement of leucine into provirion requires the concomitant synthesis of viral RNA-guanidine blocks morphogenesis at the stage of procapsid. Third, in a pulse-chase experiment with 3H-leucine, radioactivity accumulates in provirion before virion and radioactivity in provirion starts to reach a plateau while that in virions is rising. Such behavior is what would be expected for a precursor. Fourth, 3H-leucine-labeled provirion disappears after guanidine addition and labeled virions continue to appear only as long as provirions contain radioactivity. Together, these experiments strongly suggest that the provirion is the direct precursor of the virion. Probably, only in vitro experiments can prove this assertion unambiguously.
Previous evidence indicated that the procapsid is the protein precursor of the virion (15) . Even though this has not been rigorously proven, and procapsid is difficult to demonstrate in at least one poliovirus-infected cell system (MiO cells) (9), it is striking that treatment of the provirion with EDTA leads to release of the RNA with an apparently intact procapsid as the product. Whatever the process involved in release of the RNA, its occurrence makes it easier Effect of EDTA on the provirion. Provirion labeled with 14C-uridine and 3H-leucine was isolated as described in Fig. 5 3H-leucine (20 MCi/ml) was added at 3 h 15 min; at 3 h 35 min the cells were harvested by centrifugation and resuspended in complete medium supplemented with guanidine and 100-fold the normal concentration of leucine; portions of 10 ml were harvested 20 and 80 min later; cytoplasmic extracts were prepared and analyzed in sucrose-RSB gradients as described in Fig. 1 . a, At 20 min; b, at 80 min. 3 .2 x 108 infected cells were exposed to guanidine (2 mM) for 15 min and then 3H-leucine (20 ACi/ml) was added. After 15 min the cells were transferred to new medium supplemented with 100-fold the normal concentration of leucine and lacking guanidine (t = 0). At various times, 10-ml portions were harvested, cytoplasmic extracts were prepared, and they were analyzed as described in Fig. la Normalized radioactivity in particles after exposure of cells to guanidine. Radioactivity in virion, provirion and procapsid from experiment described in Fig. 9 were normalized to the content of A260 of 60S ribosomal subunit as described in Fig. 8, panel f. fraction. The viral RNA for virion formation therefore probably comes directly from its site of synthesis into the procapsid.
Formation of provirion can be detected in cell-free extracts (Fernandez-Tomas, Guttman, and Baltimore, J. Virol., 12:1181-1183). Formation of whole virions in such extracts has not yet been detected. 
